THCv is one of the lesser known cannabinoids in cannabis. Early studies suggested that THCV was not as potent as THC, with little intoxicating effects. Yet other research has suggested that the effects of THCv in the ECS can either increase or decrease depending on the dosage—in lower amounts it was not psychoactive but in higher amounts it was shown that THCv acts like THC. Many people believe that it can act as an appetite suppressant and could help reduce anxiety or stress,
B
With this new technology completed with Ginkgo the future costs will drop like a ton of bricks, put revenue straight to the bottom line. Great strategy to grow the business in countries around the world.
C
TORONTO and BOSTON, June 21, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos"), an innovative global cannabinoid company, and Ginkgo Bioworks (NYSE: DNA) (“Ginkgo”), the leading horizontal platform for cell programming, today announced the achievement of the third target productivity milestone in their partnership to produce eight cultured cannabinoids. Using Ginkgo’s platform for organism design and development, Cronos has successfully achieved the productivity target for tetrahydrocannabivarin (THCV), a cannabinoid hypothesized to reduce the appetite-enhancing property of THC. Access to additional rare cannabinoids will support Cronos’ innovation pipeline and commercialization strategy.
B
MO needs a future growth market. CBD will grow to exceed $20 bill......Once legalized THC (think alcohol alternative) is bigger.
B
June 22, CBD market set to grow from 4 Bill to over 20 Bill..... next 5 yrs
G
Wow up a whopping 2 cents on Ginko news. Boo ya
f
I'm buying CRON of course......long term, it will make me much more wealthy! And frankly.....I'm buying everything in my portfolio as every single one is down! A big opportunity for sure! I'm a buyer across the board............and guess what? The big money peeps are doing the same thing this very minute! The smart and rich are all buying! GLTR........
C
This stock will never fail and will have protection from crashing because of its connection to Altria. Whether it makes any money for shareholders will be the question. If share price continues to swirl the drain, Altria (MO) may just decide to acquire the company. This would not be a good situation for shareholder because Altria already holds a very large percentage of the company. I own alot of Altria but I do not own Crony. If Crony drops below 2.4 I will get a few thousand shares, for fun. The problem with pot stocks is there is so much pot supply. Tons and Tons of it. Altria will eventually become the dominant pot company, whether that occurs in 3 or 10 years, it will happen. The other companies will be novelty acts, because Altria will crush them because they can do all logistics cheaper better faster.
R
Last quarter Cronos Group had sales revenue of C$25/M and operational losses of C$37/M… their income statement is awful……..
R
While I’m a huge fan of Cronos Groups balance sheet, their income statement needs a lot of work.
k
Yoohoow funny. They say stocks climb back, you look at the screen, and they are DOWN. Frankly, they need them down for a long time to cover MASSIVE shorts out, on all stocks. TSLA for example.
looks like a good buy here...average price target near term 4.85 per share.. 5 is mine.
E
Altria hasnt bailed on Cronos why would i ....holding until altria sells their shares. ill stick with real companies and investors than the shorts and haters that work for yahoo and other firms
J
I took big position last week at 3.20 thats why its down this week I will let you all know when I sell, because it will take off the next day🤷♂️.
M
achieved a third target productivity milestone. This concerns the partnership between the two to develop eight cultured cannabinoids using Ginkgo’s platform for design and development.
k
Brandon brandon brandon tells the ruskies they can drop a nuke. Sure makes the future look bright.
5 is mine.